Top Story

PCI, optimal medical therapy yield similar outcomes in DECISION-CTO trial

March 27, 2017

Read the Perspective from Emmanouil S. Brilakis, MD, PhD

WASHINGTON — In the first randomized clinical trial to compare optimal medical therapy alone with PCI in patients with a coronary chronic total occlusion, the therapeutic strategy was noninferior to intervention for the primary endpoint of death, MI, stroke or any revascularization at 3 years.

The rate of the primary endpoint at 3 years in the intention-to-treat population of patients with a CTO was 19.6% in the optimal medical therapy group vs. 20.6% in the PCI group (P for noninferiority = .008). Measures of health-related quality of life, assessed by the Seattle Angina Questionnaire, were comparable during follow-up between the two groups.

Meeting NewsVideo

VIDEO: RE-CIRCUIT results on uninterrupted dabigatran in AF ablation poised to change practice

March 27, 2017
WASHINGTON — In this Cardiology Today video perspective, Jagmeet P. Singh, MD, PhD, associate chief of the cardiology division at Harvard Medical School in
FDA News

FDA designates recall of external defibrillator as Class 1

March 27, 2017
The FDA has designated Phillips Healthcare’s product recall of an external monitor and defibrillator as a Class 1 recall, the most serious kind. The recall
Meeting NewsPerspective

TAVR in bicuspid aortic stenosis more effective with newer-generation devices

March 27, 2017
WASHINGTON — Treatment of bicuspid aortic stenosis with transcatheter aortic valve replacement was comparable to transcatheter aortic valve replacement in
Meeting News

High cholesterol levels, no statins linked with increased failure rate after arthroscopic rotator cuff repair

March 27, 2017
SAN DIEGO — Patients with moderate or high cholesterol levels and who were not prescribed statins had a greater risk for failure after arthroscopic rotator cuff…
More News Headlines »